Atlas Trials

Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty

Clinical trial NCT05139030 · COMPLETED

Trial details

NCT number
NCT05139030
Sponsor
Pacira Pharmaceuticals, Inc
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Knee OsteoarthritisPain Management
Start date
2022-01-18
Primary completion
2022-07-11
Enrollment
167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.